IL13 and asthma: These features are also present during asthma exacerbation on day 4 (Fig. 4D), when the healthy and allergic asthmatic patients form separate clusters with overlap for only a few subjects: with asthmatic patients generally having higher levels of nasal IL-5 and IL-13.